Erin W Meermeier

13PUBLICATIONS
77CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Medical mycologyHaematological tumoursGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 11, 2026
Clinical Evaluation of Ex Vivo Expanded MUC1-Specific Peripheral Blood T Cells for Adoptive Immunotherapy in Relapsed/Refractory Multiple Myeloma.

|Sep 19, 2025
Reprogramming glutamine metabolism enhances BCMA-CAR T-cell fitness and therapeutic efficacy in multiple myeloma.

Flor Navarro, Teresa Lozano, Andrea Fuentes-García

|Aug 27, 2025
An immunostimulatory CELMoD combination overcomes resistance to T-cell engagers caused by a high multiple myeloma burden.

Erin W Meermeier, Kirsten Pfeffer, Caleb K Stein

|Jun 19, 2025
A natural head start to MRD negativity in multiple myeloma.

Erin W Meermeier

|May 07, 2024
The genomic landscape of Vk*MYC myeloma highlights shared pathways of transformation between mice and humans.

Francesco Maura, David G Coffey, Caleb K Stein

|Sep 28, 2023
Transcriptional Heterogeneity Overcomes Super-Enhancer Disrupting Drug Combinations in Multiple Myeloma.

Seth J Welsh, Benjamin G Barwick, Erin W Meermeier

Pageof 3

Frequent Collaborators

7 joint publications

Peter Leif Bergsagel

5 joint publications

Marta Chesi

3 joint publications

Marielle C Gold

3 joint publications

Yuliza Tafoya Alvarado